Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.


Clinical Trial Description

This is a multi-center explanatory trial of strict glycemic control for surgical patients with necrotizing soft tissue infection (NSTI). The primary objective of this study is to verify feasibility of the intervention, provide unbiased and evidence-based estimates of treatment effects, and obtain data needed to design and direct a larger multi-center trial if necessary. The multi-center trial (n >100) will have adequate power to identify a 30% difference in favorable outcome defined as discharge alive from the hospital without an amputation in less than the median number of hospital days. Secondary objectives include evaluation of specific hypotheses relating the intervention to cytokine and neutrophil responses. These preliminary data will provide the basis for future research and grant applications, lend insight into the mechanisms by which hyperglycemia results in adverse effects, and improve outcome through the development of evidence-based therapeutic strategies for patient care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00353275
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact
Status Terminated
Phase N/A
Start date August 2009
Completion date July 2011

See also
  Status Clinical Trial Phase
Completed NCT00538577 - Outcome and Related Factors of Necrotizing Fasciitis of the Limb N/A
Recruiting NCT05116956 - SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study
Completed NCT04091672 - RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction N/A
Completed NCT01731483 - Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections
Completed NCT01139112 - Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features N/A
Recruiting NCT02169128 - Severe Soft Tissue Infections: Perspectives of Patients and Significant Others
Completed NCT01790698 - Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
Completed NCT02501382 - Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
Completed NCT02180906 - Biomarkers in Patients With Flesh-eating Bacterial Infections N/A
Completed NCT02469857 - Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections Phase 3
Recruiting NCT06073301 - AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF Phase 4
Completed NCT02111161 - Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial Phase 2